Supreme Industries Intrinsic Value

SUPREMEIND • Industrial Products
Current Stock Price
₹3557.40
Primary Intrinsic Value
₹1067.22
Market Cap
₹8894 Cr
-36.4% Downside
Median Value
₹2264.00
Value Range
₹1067 - ₹3728
Assessment
Trading Above Calculated Value
Safety Margin
-57.1%

SUPREMEIND Valuation Methods Summary

Method Type Intrinsic Value Range Upside/Downside Details
P/E Based Valuation earnings ₹1067.22 ₹853.78 - ₹1280.66 -70.0% EPS: ₹51.88, Sector P/E: 12x
Book Value Method asset ₹2264.00 ₹2037.60 - ₹2490.40 -36.4% Book Value/Share: ₹2264.00, P/B: 1.0x
Revenue Multiple Method revenue ₹3102.72 ₹2792.45 - ₹3412.99 -12.8% Revenue/Share: ₹3878.40, P/S: 0.8x
EBITDA Multiple Method earnings ₹3048.44 ₹2743.60 - ₹3353.28 -14.3% EBITDA: ₹1312.00Cr, EV/EBITDA: 6x
Simple DCF (5Y) dcf ₹3728.38 ₹2982.70 - ₹4474.06 +4.8% CF Growth: 5.0%, Discount: 15%
PEG Ratio Method growth ₹1067.22 ₹960.50 - ₹1173.94 -70.0% EPS Growth: 8.0%, Fair P/E: 6.4x
Growth Adjusted P/E growth ₹1067.22 ₹960.50 - ₹1173.94 -70.0% Revenue Growth: 6.0%, Adj P/E: 8.2x
ROE Based Valuation profitability ₹3168.00 ₹2851.20 - ₹3484.80 -10.9% ROE: 11.7%, P/E Multiple: 12x
Graham Defensive Method conservative ₹1625.66 ₹1463.09 - ₹1788.23 -54.3% EPS: ₹51.88, BVPS: ₹2264.00
Method Types: Earnings Asset DCF Growth Dividend Conservative

Want to compare with current market value? Check SUPREMEIND share price latest .

Valuation Comparison Chart

SUPREMEIND Intrinsic Value Analysis

What is the intrinsic value of SUPREMEIND?

Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Supreme Industries (SUPREMEIND) is ₹2264.00 (median value). With the current market price of ₹3557.40, this represents a -36.4% variance from our estimated fair value.

The valuation range spans from ₹1067.22 to ₹3728.38, indicating ₹1067.22 - ₹3728.38.

Is SUPREMEIND undervalued or overvalued?

Based on our multi-method analysis, Supreme Industries (SUPREMEIND) appears to be trading above calculated value by approximately 36.4%.

Financial Health Analysis

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Current Ratio 16.09 Industry Standard: 2.0+ Above 2.0 Measures short-term liquidity capacity
Debt to Equity Ratio 1.27 Industry Standard: <0.5 Above 1.0 Indicates financial leverage level
Return on Equity 11.7% Industry Standard: 15%+ Above 10% Measures shareholder return efficiency
Operating Margin 12.0% Industry Standard: 20%+ Above 10% Indicates operational efficiency level
Asset Turnover Ratio 1.35x Industry Standard: 1.0x+ Above 1.0x Measures asset utilization efficiency

Cash Flow Quality Analysis

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2025 ₹1,004 Cr ₹605 Cr Positive Free Cash Flow 8/10
March 2024 ₹1,413 Cr ₹1,118 Cr Positive Free Cash Flow 8/10
March 2023 ₹890 Cr ₹718 Cr Positive Free Cash Flow 8/10
March 2022 ₹470 Cr ₹269 Cr Positive Free Cash Flow 8/10
March 2021 ₹1,246 Cr ₹1,147 Cr Positive Free Cash Flow 8/10